Reversible pulmonary hypertension in heart transplant candidates does not obligatorily predict worse outcome post-transplantation [4]

Journal of Heart and Lung Transplantation

Volumn 24, Issue 11, 2005, Pages 1998-1999

  Klotz, Stefan ^a   Schmid, Christof ^a   Scheld, Hans H ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INCIDENCE; LETTER; LUNG VASCULAR RESISTANCE; MORTALITY; POSTOPERATIVE PERIOD; PREDICTION; PRESSURE GRADIENT; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; TREATMENT OUTCOME;

COMORBIDITY; HEART DISEASES; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; PROGNOSIS;

EID: 27844493820     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.03.006     Document Type: Letter

References (10)

1. J. Butler, M.A. Stankewicz, J. Wu Pretransplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation J Heart Lung Transplant 24 2005 170 177
2. S. Klotz, M.C. Deng, D. Hanafy Reversible pulmonary hypertension in heart transplant candidates - pretransplant evaluation and outcome after orthotopic heart transplantation Eur J Heart Fail 5 2003 645 653
3. J.K. Kirklin, D.C. Naftel, J.W. Kirklin Pulmonary vascular resistance and the risk of heart transplantation J Heart Transplant 7 1988 331 336
4. A. Costard-Jackle, M.B. Fowler Influence of preoperative pulmonary artery pressure on mortality after heart transplantation testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group JAMA 19 1992 48 54
5. G. Tenderich, M.M. Koerner, B. Stuettgen Pre-existing elevated pulmonary vascular resistance long-term hemodynamic follow-up and outcome of recipients after orthotopic heart transplantation J Cardiovasc Surg (Torino) 41 2000 215 219
6. G. Tenderich, M.M. Koerner, B. Stuettgen Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient > 15 mm Hg or > 5 wood) predict early and long-term results after orthotopic heart transplantation? Transplant Proc 30 1998 1130 1131
7. F. Iberer, A. Wasler, K. Tscheliessnigg Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation J Heart Lung Transplant 12 1993 173 178
8. S. Murali, B.F. Uretsky, J.M. Armitage Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension J Heart Lung Transplant 11 1992 716 723
9. C. Espinoza, N. Manito, J. Roca Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation importance in the postoperative morbidity and mortality Transplant Proc 31 1999 2503 2504
10. M.R. Costanzo, S. Augustine, R. Bourge Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association Circulation 92 1995 3593 3612